These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33483742)

  • 1. Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans.
    Llewellyn HP; Vaidya VS; Wang Z; Peng Q; Hyde C; Potter D; Wang J; Zong Q; Arat S; Martin M; Masek-Hammerman K; Warner R; Johnson K; Kullak-Ublick GA; Aithal GP; Dear JW; Ramaiah SK
    Toxicol Sci; 2021 Apr; 181(1):23-34. PubMed ID: 33483742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
    Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
    Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).
    Scullion KM; MacIntyre IM; Sloan-Dennison S; Clark B; Fineran P; Mair J; Creasey D; Rathmell C; Faulds K; Graham D; Webb DJ; Dear JW
    Toxicol Sci; 2024 May; 199(2):203-209. PubMed ID: 38521541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat.
    Thulin P; Hornby RJ; Auli M; Nordahl G; Antoine DJ; Starkey Lewis P; Goldring CE; Park BK; Prats N; Glinghammar B; Schuppe-Koistinen I
    Biomarkers; 2017 Jul; 22(5):461-469. PubMed ID: 27978773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.
    Antoine DJ; Dear JW; Lewis PS; Platt V; Coyle J; Masson M; Thanacoody RH; Gray AJ; Webb DJ; Moggs JG; Bateman DN; Goldring CE; Park BK
    Hepatology; 2013 Aug; 58(2):777-87. PubMed ID: 23390034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies.
    Dear JW; Clarke JI; Francis B; Allen L; Wraight J; Shen J; Dargan PI; Wood D; Cooper J; Thomas SHL; Jorgensen AL; Pirmohamed M; Park BK; Antoine DJ
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):104-113. PubMed ID: 29146439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection.
    Rupprechter SAE; Sloan DJ; Oosthuyzen W; Bachmann TT; Hill AT; Dhaliwal K; Templeton K; Matovu J; Sekaggya-Wiltshire C; Dear JW
    Br J Clin Pharmacol; 2021 Aug; 87(8):3206-3217. PubMed ID: 33432705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum biomarkers of isoniazid-induced liver injury: Aminotransferases are insufficient, and OPN, L-FABP and HMGB1 can be promising novel biomarkers.
    Cheng X; Zhu JL; Li Y; Luo WW; Xiang HR; Zhang QZ; Peng WX
    J Appl Toxicol; 2022 Mar; 42(3):516-528. PubMed ID: 34494278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of emerging biomarkers of liver injury in human subjects.
    Schomaker S; Warner R; Bock J; Johnson K; Potter D; Van Winkle J; Aubrecht J
    Toxicol Sci; 2013 Apr; 132(2):276-83. PubMed ID: 23339181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.
    Cueto-Sánchez A; Niu H; Álvarez-Álvarez I; López-Longarela B; Del Campo-Herrera E; Ortega-Alonso A; García-Cortés M; Pinazo-Bandera J; Sanabria-Cabrera J; Díaz-Mochón JJ; Lucena MI; Andrade RJ; Stephens C; Robles-Díaz M
    Br J Clin Pharmacol; 2023 Aug; 89(8):2497-2507. PubMed ID: 36965054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
    Schomaker S; Potter D; Warner R; Larkindale J; King N; Porter AC; Owens J; Tomlinson L; Sauer JM; Johnson K; Aubrecht J
    PLoS One; 2020; 15(5):e0229753. PubMed ID: 32407333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Performance Evaluation of Liver and Skeletal Muscle-Specific miRNAs in Rat Plasma to Detect Drug-Induced Injury.
    Bailey WJ; Barnum JE; Erdos Z; LaFranco-Scheuch L; Lane P; Vlasakova K; Sistare FD; Glaab WE
    Toxicol Sci; 2019 Mar; 168(1):110-125. PubMed ID: 30496518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.
    Vliegenthart AD; Shaffer JM; Clarke JI; Peeters LE; Caporali A; Bateman DN; Wood DM; Dargan PI; Craig DG; Moore JK; Thompson AI; Henderson NC; Webb DJ; Sharkey J; Antoine DJ; Park BK; Bailey MA; Lader E; Simpson KJ; Dear JW
    Sci Rep; 2015 Oct; 5():15501. PubMed ID: 26489516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transformation in biomarker detection and management of drug-induced liver injury.
    Church RJ; Watkins PB
    Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.
    Antoine DJ; Jenkins RE; Dear JW; Williams DP; McGill MR; Sharpe MR; Craig DG; Simpson KJ; Jaeschke H; Park BK
    J Hepatol; 2012 May; 56(5):1070-1079. PubMed ID: 22266604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.
    Thulin P; Nordahl G; Gry M; Yimer G; Aklillu E; Makonnen E; Aderaye G; Lindquist L; Mattsson CM; Ekblom B; Antoine DJ; Park BK; Linder S; Harrill AH; Watkins PB; Glinghammar B; Schuppe-Koistinen I
    Liver Int; 2014 Mar; 34(3):367-78. PubMed ID: 24118944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix and Sampling Effects on Quantification of Protein Biomarkers of Drug-Induced Liver Injury.
    Anselm V; Sommersdorf C; Carrasco-Triguero M; Katavolos P; Planatscher H; Steinhilber A; Joos T; Poetz O
    J Proteome Res; 2021 Nov; 20(11):4985-4994. PubMed ID: 34554759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies.
    Sharapova T; Devanarayan V; LeRoy B; Liguori MJ; Blomme E; Buck W; Maher J
    Vet Pathol; 2016 Jan; 53(1):211-21. PubMed ID: 26123229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats.
    Park HK; Jo W; Choi HJ; Jang S; Ryu JE; Lee HJ; Lee H; Kim H; Yu ES; Son WC
    J Vet Sci; 2016 Mar; 17(1):45-51. PubMed ID: 27051339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).
    Morrison EE; Oatey K; Gallagher B; Grahamslaw J; O'Brien R; Black P; Oosthuyzen W; Lee RJ; Weir CJ; Henriksen D; Dear JW;
    EBioMedicine; 2019 Aug; 46():423-430. PubMed ID: 31311721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.